Results 6,541-6,560 of 11,299 for speaker:Colm Burke

Joint Oireachtas Committee on Health: Rare Diseases: Discussion (Resumed) (22 Jun 2022)

Colm Burke: It is also about cross-border healthcare in the sense this is a small country and we will not necessarily have all of the expertise here. If we working on pricing with five other countries, could we also be working with them on the provision of expertise?

Joint Oireachtas Committee on Health: Rare Diseases: Discussion (Resumed) (22 Jun 2022)

Colm Burke: Going back to the genomics issue whereby there is one expert per 285,000 people in Northern Ireland, has there been engagement with Northern Ireland on sharing expertise so that expertise is available that might not otherwise be, and is there is a quid pro quofor Northern Ireland? has there been any engagement on working together with those in that area in Northern Ireland?

Joint Oireachtas Committee on Health: Rare Diseases: Discussion (Resumed) (22 Jun 2022)

Colm Burke: There is an advantage. For instance, we already have people coming from Northern Ireland to Dublin for particular medical treatments. Likewise, we have people from the South going to Northern Ireland for treatment. In this area, could there be more co-operation and, as a result, there would be a benefit for the entire island?

Written Answers — Department of Enterprise, Trade and Employment: Medicinal Products (13 Jul 2022)

Colm Burke: 68. To ask the Minister for Enterprise, Trade and Employment if he has engaged with the Department of the Taoiseach in relation to formulating a position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38307/22]

Written Answers — Department of Enterprise, Trade and Employment: Medicinal Products (13 Jul 2022)

Colm Burke: 69. To ask the Minister for Enterprise, Trade and Employment if he has engaged with the Department of Health in relation to formulating a position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38308/22]

Written Answers — Department of Enterprise, Trade and Employment: Intellectual Property (13 Jul 2022)

Colm Burke: 70. To ask the Minister for Enterprise, Trade and Employment his views on whether intellectual property rights should be protected especially in the development of innovative medicinal products; and if he will make a statement on the matter. [38309/22]

Written Answers — Department of Enterprise, Trade and Employment: Medicinal Products (13 Jul 2022)

Colm Burke: 71. To ask the Minister for Enterprise, Trade and Employment his views on whether Europe has been losing ground to the United States and Asia, for biopharmaceutical research and manufacturing investments; and if he will make a statement on the matter. [38310/22]

Written Answers — Department of Enterprise, Trade and Employment: Medicinal Products (13 Jul 2022)

Colm Burke: 72. To ask the Minister for Enterprise, Trade and Employment if the adoption of a strong pro-innovation position in relation to the European Pharmaceutical Strategy has the potential to protect existing jobs, create new jobs and further help new treatments to originate and be developed in Ireland and Europe; and if he will make a statement on the matter. [38311/22]

Written Answers — Department of Enterprise, Trade and Employment: Medicinal Products (13 Jul 2022)

Colm Burke: 73. To ask the Minister for Enterprise, Trade and Employment his views on whether there is a role for Ireland, along with other economically advanced, similar-sized countries, in supporting the protection of innovation in the European Union Pharmaceutical Strategy in order that Ireland remains competitive for new investments and raise standards of care; and if he will make a statement on the...

Written Answers — Department of Defence: Defence Forces (13 Jul 2022)

Colm Burke: 290. To ask the Taoiseach and Minister for Defence if it is intended that new direct entry medical officers in the Defence Forces will be entered into the specialist division in general practice; and if he will make a statement on the matter. [38257/22]

Written Answers — Department of Defence: Defence Forces (13 Jul 2022)

Colm Burke: 291. To ask the Taoiseach and Minister for Defence if the military medicine training scheme to induct new medical practitioner trainees will be advertised in 2022 and if whatever barriers and issues which prevented such intake in 2021 will be removed and resolved; and if he will make a statement on the matter. [38258/22]

Written Answers — Department of Education and Skills: Research and Development (13 Jul 2022)

Colm Burke: 437. To ask the Minister for Education and Skills if his Department has engaged with officials from the Department of Health in relation to the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38793/22]

Written Answers — Department of Education and Skills: Intellectual Property (13 Jul 2022)

Colm Burke: 438. To ask the Minister for Education and Skills the level of engagement that his Department has had to date with the Department of Enterprise, Trade and Employment in relation to the protection of intellectual property rights within the research and development and innovation sectors; and if he will make a statement on the matter. [38794/22]

Written Answers — Department of Education and Skills: Intellectual Property (13 Jul 2022)

Colm Burke: 439. To ask the Minister for Education and Skills his views on whether intellectual property rights should be protected especially in the development of innovative medicinal products; and if he will make a statement on the matter. [38795/22]

Written Answers — Department of Education and Skills: Intellectual Property (13 Jul 2022)

Colm Burke: 440. To ask the Minister for Education and Skills the level of interaction that he has had with industry representatives about trade-related intellectual property rights; and if he will make a statement on the matter. [38796/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 454. To ask the Minister for Health if his Department’s white paper on Enterprise Policy will be taken into account as part of Ireland’s position in respect of the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38312/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 456. To ask the Minister for Health if he has engaged with the Department of Taoiseach and the Department of Enterprise, Trade and Employment in relation to formulating a Government position on the European Union Pharmaceutical Strategy. [38786/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 457. To ask the Minister for Health if he intends to set up a cross-Departmental working group to consider the European Union Pharmaceutical Strategy and its implications for biopharmaceutical innovation in Ireland. [38787/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 500. To ask the Minister for Health if he intends to set up a cross-Departmental working group to consider the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38282/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 501. To ask the Minister for Health if he intends to launch a public consultation for industry and interested stakeholders to assist in developing Ireland’s position in relation to the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38283/22]